<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>biomarker discovery &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/biomarker-discovery/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 24 Jan 2026 07:56:12 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>biomarker discovery &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>ProteoBoostR: Revolutionizing Clinical Proteomics with AI</title>
		<link>https://bioengineer.org/proteoboostr-revolutionizing-clinical-proteomics-with-ai/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 24 Jan 2026 07:55:51 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biomarker discovery]]></category>
		<category><![CDATA[Biyobelirteç Keşfi]]></category>
		<category><![CDATA[İşte içeriğe uygun 5 etiket: **Klinik Proteomik]]></category>
		<category><![CDATA[İşte içerik için uygun 5 etiket (virgülle ayrılmış): **Clinical Proteomics]]></category>
		<category><![CDATA[Machine Learning]]></category>
		<category><![CDATA[Makine Öğrenimi]]></category>
		<category><![CDATA[Personalized Medicine** **Seçimlerin Gerekçesi:** 1. **Clinical Proteomics:** Makalenin ana konusu ve araştırma alanı. İçerik boyunca sürekli vurgulanıyor. 2.]]></category>
		<category><![CDATA[ProteoBoostR]]></category>
		<category><![CDATA[Veri Analizi** **Açıklama:** 1. **Klinik Proteomik:** Makalenin ana konusu ve ProteoBoostR'ın uygulama alanı. 2. **Makine Öğren]]></category>
		<category><![CDATA[Yapay zeka]]></category>
		<guid isPermaLink="false">https://bioengineer.org/proteoboostr-revolutionizing-clinical-proteomics-with-ai/</guid>

					<description><![CDATA[In the realm of clinical proteomics, innovative tools are crucial for harnessing the vast amounts of proteomic data generated in research laboratories and medical settings. Among such groundbreaking resources is ProteoBoostR, an interactive framework specifically designed for supervised machine learning applications. This tool is set to revolutionize how researchers and clinicians can analyze and interpret [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320202</post-id>	</item>
		<item>
		<title>Exploring the Genomic Features of Endometrial Polyps</title>
		<link>https://bioengineer.org/exploring-the-genomic-features-of-endometrial-polyps/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jan 2026 19:12:47 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biomarker discovery]]></category>
		<category><![CDATA[biomarkers]]></category>
		<category><![CDATA[Clinical Stratification]]></category>
		<category><![CDATA[Endometrial Microbiome]]></category>
		<category><![CDATA[Endometrial Polyps]]></category>
		<category><![CDATA[Genomic Landscape]]></category>
		<category><![CDATA[Genomic Profiling]]></category>
		<category><![CDATA[Microbiome Interaction]]></category>
		<category><![CDATA[Mutation Analysis]]></category>
		<category><![CDATA[targeted therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/exploring-the-genomic-features-of-endometrial-polyps/</guid>

					<description><![CDATA[In a groundbreaking study that could change our understanding of gynecological health, researchers have delved into the genomic landscape of endometrial polyps. This research, conducted by a team led by Reinikka, Mehine, and von Nandelstadh, was published in the prestigious journal Genome Medicine. Endometrial polyps, often regarded as benign growths in the uterine lining, can [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319966</post-id>	</item>
		<item>
		<title>Unraveling Small-Cell Lung Cancer: A Multi-Omic Approach</title>
		<link>https://bioengineer.org/unraveling-small-cell-lung-cancer-a-multi-omic-approach/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jan 2026 04:10:43 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[biomarker discovery]]></category>
		<category><![CDATA[biomarkers]]></category>
		<category><![CDATA[multi-omic profiling]]></category>
		<category><![CDATA[personalized medicine]]></category>
		<category><![CDATA[personalized oncology]]></category>
		<category><![CDATA[small-cell lung cancer]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/unraveling-small-cell-lung-cancer-a-multi-omic-approach/</guid>

					<description><![CDATA[In a groundbreaking study, researchers have conducted a comprehensive multi-omic profiling of small-cell lung cancer (SCLC), revealing crucial insights into its heterogeneity, microenvironment, and biomarker landscape. This innovative approach combines genomic, transcriptomic, proteomic, and metabolomic analyses, providing a holistic understanding of one of the most aggressive forms of lung cancer. The findings not only shed [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319634</post-id>	</item>
		<item>
		<title>Innovative Frameworks Boost Extracellular Vesicle Biomarker Discovery</title>
		<link>https://bioengineer.org/innovative-frameworks-boost-extracellular-vesicle-biomarker-discovery/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 23:45:50 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[AI in Biomarker Discovery]]></category>
		<category><![CDATA[AI-driven EV biomarkers]]></category>
		<category><![CDATA[and solutions]]></category>
		<category><![CDATA[Based on the article's focus on AI]]></category>
		<category><![CDATA[biomarker discovery]]></category>
		<category><![CDATA[challenges]]></category>
		<category><![CDATA[Clinical biomarker validation]]></category>
		<category><![CDATA[Clinical Translation Challenges**]]></category>
		<category><![CDATA[Deep Learning for EVs]]></category>
		<category><![CDATA[EVs]]></category>
		<category><![CDATA[Explainable AI (XAI)]]></category>
		<category><![CDATA[Explainable AI in biomedicine]]></category>
		<category><![CDATA[here are 5 appropriate tags: **Extracellular Vesicle Biomarkers]]></category>
		<category><![CDATA[multi-omics data integration]]></category>
		<category><![CDATA[Protein structure prediction]]></category>
		<guid isPermaLink="false">https://bioengineer.org/innovative-frameworks-boost-extracellular-vesicle-biomarker-discovery/</guid>

					<description><![CDATA[The intersection of artificial intelligence (AI) and extracellular vesicle (EV) biomarker discovery represents an exciting frontier in biomedical research, promising significant advancements in diagnostic capabilities and therapeutic interventions. Extracellular vesicles, which are nanoscale lipid bilayer particles secreted by various cell types, play critical roles in intercellular communication and are increasingly recognized as potential biomarkers for [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318626</post-id>	</item>
		<item>
		<title>Revolutionary Method Enhances Proteomic Profiling of EVs</title>
		<link>https://bioengineer.org/revolutionary-method-enhances-proteomic-profiling-of-evs/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 17 Jan 2026 14:52:46 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biomarker discovery]]></category>
		<category><![CDATA[Cerebrospinal fluid** **Seçimlerin gerekçesi:** 1. **Tetraspanin-based immunocapture:** Makalenin odak noktası olan yenilikçi yöntem. 2.]]></category>
		<category><![CDATA[extracellular vesicles]]></category>
		<category><![CDATA[İşte bu içerik için 5 uygun etiket (virgülle ayrılmış): **Tetraspanin-based immunocapture]]></category>
		<category><![CDATA[proteomic profiling]]></category>
		<guid isPermaLink="false">https://bioengineer.org/revolutionary-method-enhances-proteomic-profiling-of-evs/</guid>

					<description><![CDATA[In the ever-evolving field of proteomics, researchers are continuously seeking innovative methodologies to enhance biomarker discovery. Recent advancements have spotlighted the potential of tetraspanin-based immunocapture techniques as a novel solution for the high-depth proteomic profiling of extracellular vesicles (EVs) derived from cerebrospinal fluid (CSF). This emerging approach presents exciting opportunities to unlock the biochemical secrets [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">317772</post-id>	</item>
		<item>
		<title>Metabolome Tracking from Pregnancy Predicts Childhood Disorders</title>
		<link>https://bioengineer.org/metabolome-tracking-from-pregnancy-predicts-childhood-disorders/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 08 Jan 2026 01:35:54 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biomarker discovery]]></category>
		<category><![CDATA[early diagnosis]]></category>
		<category><![CDATA[Maternal metabolome]]></category>
		<category><![CDATA[Metabolome tracking]]></category>
		<category><![CDATA[neurodevelopmental disorders]]></category>
		<guid isPermaLink="false">https://bioengineer.org/metabolome-tracking-from-pregnancy-predicts-childhood-disorders/</guid>

					<description><![CDATA[In a groundbreaking longitudinal study set to transform our understanding of neurodevelopmental disorders, researchers have meticulously charted the metabolomic landscape from pregnancy through early childhood. This pioneering research, led by Wang, Jepsen, Vinding, and colleagues, delves deep into the intricate metabolic profiles of mothers and their children, unraveling novel biochemical signatures that could predict the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">314688</post-id>	</item>
		<item>
		<title>Plasma Protein Profiling Detects Cancer in Symptomatic Patients</title>
		<link>https://bioengineer.org/plasma-protein-profiling-detects-cancer-in-symptomatic-patients/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 29 Dec 2025 04:40:32 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biomarker discovery]]></category>
		<category><![CDATA[Cancer Detection]]></category>
		<category><![CDATA[early cancer diagnosis]]></category>
		<category><![CDATA[Plasma Protein Profiling]]></category>
		<category><![CDATA[Proteomics in Oncology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/plasma-protein-profiling-detects-cancer-in-symptomatic-patients/</guid>

					<description><![CDATA[In a groundbreaking advancement for cancer diagnostics, researchers have unveiled a plasma protein profiling technique capable of predicting cancer in patients displaying non-specific symptoms. This innovative approach represents a significant leap forward in oncology, as it provides a minimally invasive, highly sensitive method to detect malignancies that often elude early clinical recognition. The study, recently [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">311976</post-id>	</item>
		<item>
		<title>Proteome Atlas Unveils Diabetic Retinopathy Risks</title>
		<link>https://bioengineer.org/proteome-atlas-unveils-diabetic-retinopathy-risks/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 31 Oct 2025 21:26:53 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biomarker discovery]]></category>
		<category><![CDATA[diabetic retinopathy]]></category>
		<category><![CDATA[Molecular mechanisms]]></category>
		<category><![CDATA[proteome atlas]]></category>
		<category><![CDATA[risk prediction]]></category>
		<guid isPermaLink="false">https://bioengineer.org/proteome-atlas-unveils-diabetic-retinopathy-risks/</guid>

					<description><![CDATA[In a groundbreaking study that promises to reshape our understanding of diabetic retinopathy, researchers have unveiled an unprecedented proteome atlas that maps the intricate molecular landscape of this debilitating retinal disease. Published recently in Nature Communications, this work represents a paradigm shift in both the mechanistic insights and predictive capabilities regarding diabetic retinopathy, a leading [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">289925</post-id>	</item>
		<item>
		<title>Microsampling Advances in Mass Spectrometry Proteomics</title>
		<link>https://bioengineer.org/microsampling-advances-in-mass-spectrometry-proteomics/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 17 Oct 2025 03:48:31 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biomarker discovery]]></category>
		<category><![CDATA[clinical diagnostics]]></category>
		<category><![CDATA[mass spectrometry proteomics]]></category>
		<category><![CDATA[microsampling innovations]]></category>
		<category><![CDATA[personalized medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/microsampling-advances-in-mass-spectrometry-proteomics/</guid>

					<description><![CDATA[In the rapidly evolving field of proteomics, researchers are continuously seeking innovative techniques to enhance sensitivity and efficiency in biomarker discovery. One such technique gaining prominence is microsampling, a method that allows scientists to analyze protein content from minimal biological samples. In a groundbreaking review, Campbell et al. (2025) explore the transformative potential of microsampling [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">282632</post-id>	</item>
		<item>
		<title>Immunomics Unlocks Biomarkers for Liver Fluke Cancer</title>
		<link>https://bioengineer.org/immunomics-unlocks-biomarkers-for-liver-fluke-cancer/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 02 Jul 2025 22:01:33 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[biomarker discovery]]></category>
		<category><![CDATA[cholangiocarcinoma detection]]></category>
		<category><![CDATA[immunomics]]></category>
		<category><![CDATA[machine learning in immunology]]></category>
		<category><![CDATA[Opisthorchis viverrini]]></category>
		<guid isPermaLink="false">https://bioengineer.org/immunomics-unlocks-biomarkers-for-liver-fluke-cancer/</guid>

					<description><![CDATA[In a groundbreaking advancement that could reshape the landscape of infectious disease diagnostics and cancer detection, researchers have unveiled an innovative immunomics-guided approach targeting human liver fluke infections and the devastating cholangiocarcinoma cancers they often provoke. This pioneering study leverages cutting-edge immunological and computational techniques to identify novel biomarkers, providing a powerful new window into [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">251227</post-id>	</item>
	</channel>
</rss>
